Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 4/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | PDE4A | P27815 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5655364 | 0.95 | TLR8 (0.57) | ALDH1A1KMT2APOLBTLR8LMNA | |
| SCHEMBL27968081 | 0.93 | TLR8 (0.56) | ALDH1A1KMT2APOLBTLR8LMNA | |
| SCHEMBL11669837 | 0.93 | TLR8 (0.56) | ALDH1A1KMT2APOLBTLR8LMNA | |
| SCHEMBL9535005 | 0.93 | TLR8 (0.56) | ALDH1A1KMT2APOLBTLR8LMNA | |
| SCHEMBL27968084 | 0.93 | TLR8 (0.56) | ALDH1A1KMT2APOLBTLR8LMNA | |
| SCHEMBL27968082 | 0.93 | TLR8 (0.56) | ALDH1A1KMT2APOLBTLR8LMNA | |
| SCHEMBL28813838 | 0.93 | TLR8 (0.56) | ALDH1A1KMT2APOLBTLR8LMNA | |
| SCHEMBL1206348 | 0.89 | ALDH1A1 (0.43) | ALDH1A1KMT2APOLBTLR8SMN1; SMN2 | |
| SCHEMBL15332214 | 0.84 | KMT2A (0.38) | ALDH1A1KMT2APOLBTLR8CA12 | |
| SCHEMBL16655334 | 0.83 | ALDH1A1 (0.39) | ALDH1A1KMT2APOLBTLR8CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109692674-B | Chiral MOC liquid chromatographic separation column for resolving racemic compound | 云南师范大学 | 2021-12-03 | — | — | CN | claimed |
| CN-121748449-B | Imidazole high-temperature proton exchange membrane with twisted structure and preparation method thereof | 东北大学 | 2026-04-28 | — | — | CN | disclosed |
| CN-121748449-A | Imidazole high-temperature proton exchange membrane with twisted structure and preparation method thereof | 东北大学 | 2026-03-27 | — | — | CN | disclosed |
| CN-116178362-B | Aggregation-induced emission material based on benzothiazole hydrazone, and preparation method and application thereof | 河南农业大学 | 2025-03-04 | — | — | CN | disclosed |
| CN-117285516-A | Dehydrogenated phenyl achyranthis statin compound, preparation method and application thereof | 大连万众益生大健康有限公司 | 2023-12-26 | — | — | CN | disclosed |
| CN-116178362-A | Aggregation-induced emission material based on benzothiazole hydrazone, and preparation method and application thereof | 河南农业大学 | 2023-05-30 | — | — | CN | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| CN-109692674-B | Chiral MOC liquid chromatographic separation column for resolving racemic compound | 云南师范大学 | 2021-12-03 | — | — | CN | disclosed |
| CN-109692674-B | Chiral MOC liquid chromatographic separation column for resolving racemic compound | 云南师范大学 | 2021-12-03 | — | — | CN | disclosed |
| CN-107250128-B | Cyclic amine derivatives and its medical usage | 东丽株式会社 | 2019-07-26 | — | — | CN | disclosed |
| EP-2725024-A1 | AZOLE HETEROCYCLIC COMPOUND, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE | Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) | 2014-04-30 | — | — | EP | disclosed |
| EP-2725024-A1 | AZOLE HETEROCYCLIC COMPOUND, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE | Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) | 2014-04-30 | — | — | EP | disclosed |
| WO-2013000108-A1 | AZOLE HETEROCYLIC COMPOUNDS, PREPARATION METHODS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | 中国科学院上海药物研究所 (CN) | 2013-01-03 | — | — | WO | disclosed |
| US-7262185-B2 | Benzazepine derivative, process for producing the same, and use | TAKEDA CHEMICAL INDUSTRIES LTD. (JP) | 2007-08-28 | — | — | US | disclosed |
| WO-2005082892-A2 | TRIAZOLE COMPOUNDS AS ANTIBACTERIAL AGENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | DR. REDDY'S LABORATORIES LTD. (IN) | 2005-09-09 | — | — | WO | disclosed |
| US-20040235822-A1 | Benzazepine derivative, process for producing the same, and use | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-11-25 | — | — | US | disclosed |
| EP-1422228-A1 | BENZAZEPINE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE | Takeda Chemical Industries, Ltd. (JP) | 2004-05-26 | — | — | EP | disclosed |
| US-5604224-A | NEURODEGENERATIVE DISORDERS | STERLING WINTHROP INC. (US) | 1997-02-18 | — | — | US | disclosed |
| US-5569655-A | Substituted heterocyclylisoquinolinium salts and compositions and method of use thereof | STERLING WINTHROP INC. (US) | 1996-10-29 | — | — | US | disclosed |
| EP-0647641-A1 | Substituted heterocyclylisoquinolinium salts and compositions and methods of usethereof | STERLING WINTHROP INC. (US) | 1995-04-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040235822-A1 | Benzazepine derivative, process for producing the same, and use | CYP1B1, CYP1A1, CYP2E1 | ALDH1A1 519/4885KMT2A 391/4885POLB 3578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.